OpenAlex
PricingAboutJobs
Log inGet started
Work

Metronomic oral cyclophosphamide prednisolone chemotherapy is an effective treatment for metastatic hormone-refractory prostate cancer after docetaxel failure.

PubMed

Year: 2010
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: Sylvain Ladoire, Jean Christophe Eymard, Sylvie Zanetta, Grégoire Mignot, Etienne Martin, Isabelle Kermarrec, Eric Mourey, Frédéric Michel, Luc Cormier, François Ghiringhelli
Institutions: Inserm, Centre Georges François Leclerc
Language: English

Topic: Prostate Cancer Treatment and Research
Subfield: Cancer Research
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: castration-resistant prostate cancer, metastatic prostate cancer, metronomic chemotherapy, cyclophosphamide, prednisolone, oral chemotherapy, PSA response, analgesia, progression-free survival, overall survival, treatment toxicity
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2188158235
FWCI: 0.985
Cites: 45
Cited by: 49
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms